Corebridge Financial (CRBG)

NYSEFinancialsAsset ManagementSnapshot 2026-10-23

$34.13-4.10%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Corebridge Financial’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

-0.8%

+10% or more+5%0%−5%−10% or less

5.77 → 5.73 EPS · FY ending Dec 31, 2027 · 11 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 11 to 11; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	5.51B
EPS	—	1.166
Annual ending 2026-12-31
Revenue	—	19.13B
EPS	—	4.573
Annual ending 2027-12-31
Revenue	—	20.97B
EPS	—	5.725

Management figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Return $1.4 billion to shareholders in 2026-Q1	It returned $1.4 billion to shareholders in 2026-Q1.	Intact	Capital returned falls below $1 billion in 2026-Q1	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Management stated this priority in 4 consecutive quarters from 2025-Q3 through 2026-Q2. Capital returned to shareholders included $2.6 billion in 2025 and $1.8 billion in the first half of 2026 via dividends and share repurchases. Dividend per share was consistently maintained at $0.25. The trajectory shows consistent delivery on capital return commitments. Delivery assessment Oct 24, 2026
EPS reaches at least $4.42 in 2026	Profit per share should reach $4.42 in 2026.	Improving	EPS falls below $4.00 in FY26	Diluted EPS: $-0.04 per share FY2026-Q2; GAAP. Published target: >=4.42 USD per share. Target period is not explicitly aligned with this observation. Source published Aug 5, 2026-0.04 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: cbe1b3de-f717-470d-86c7-46824cd00cd3. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Complete merger with Equitable	The merger with Equitable will improve scale and cash flow.	Intact	Merger is delayed beyond FY26 or cancelled	Qualitative condition This condition has no defined numerical measure. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 disclosures including 2026-Q1 and 2026-Q2 press releases and a May 2026 leadership announcement. The merger has reached shareholder approval and regulatory filings remain on track, with expected close by year-end 2026. Management is focused on execution and integration, indicating active delivery on this strategic priority. Delivery assessment Oct 24, 2026
Revenue growth near 10% per year	A primary condition in Corebridge Financial's published investment case. The stated target is >=10% YoY.	Intact	YoY revenue growth falls below 7% next year	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 disclosures including 2026-Q1 and 2026-Q2 press releases and a May 2026 leadership announcement. The merger has reached shareholder approval and regulatory filings remain on track, with expected close by year-end 2026. Management is focused on execution and integration, indicating active delivery on this strategic priority. Delivery assessment Oct 24, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$5.73

$5.77 → $5.73 · observed estimates

FY2027 revenue$20.97B

$21.88B → $20.97B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$5.77	$21,882,859,030	14 / 6
2026-07-25	$5.77	$21,882,859,030	14 / 6
2026-07-26	$5.78	$21,900,158,561	10 / 5
2026-07-27	$5.75	$21,906,593,460	14 / 7
2026-07-28	$5.75	$21,906,593,460	14 / 7
2026-07-29	$5.75	$21,906,593,460	14 / 7
2026-07-30	$5.77	$21,900,158,561	10 / 5
2026-07-31	$5.77	$21,900,158,561	10 / 5
2026-08-01	$5.77	$21,900,158,561	10 / 5
2026-08-02	$5.75	$21,906,593,460	14 / 7
2026-08-03	$5.77	$21,900,158,561	10 / 5
2026-08-04	$5.75	$21,906,593,460	14 / 7
2026-08-05	$5.75	$21,906,593,460	14 / 7
2026-08-06	$5.75	$21,906,593,460	14 / 7
2026-08-07	$5.76	$21,870,112,544	10 / 5
2026-08-08	$5.76	$21,858,019,270	15 / 8
2026-08-09	$5.76	$21,858,019,270	15 / 8
2026-08-10	$5.76	$21,870,112,544	10 / 5
2026-08-11	$5.76	$21,870,112,544	10 / 5
2026-08-12	$5.76	$21,870,112,544	10 / 5
2026-08-13	$5.76	$21,870,112,544	10 / 5
2026-08-14	$5.76	$21,870,112,544	10 / 5
2026-08-15	$5.76	$21,870,112,544	10 / 6
2026-08-16	$5.76	$21,870,112,544	10 / 6
2026-08-17	$5.76	$21,870,112,544	10 / 6
2026-08-18	$5.76	$21,870,112,544	10 / 6
2026-08-19	$5.76	$21,870,112,544	10 / 6
2026-08-20	$5.76	$21,827,546,061	10 / 6
2026-08-21	$5.76	$21,827,546,061	10 / 6
2026-08-22	$5.77	$21,827,546,061	10 / 6
2026-08-23	$5.77	$21,827,546,061	10 / 6
2026-08-24	$5.77	$21,827,546,061	10 / 6
2026-08-25	$5.77	$21,827,546,061	10 / 6
2026-08-26	$5.77	$21,671,515,544	10 / 6
2026-08-27	$5.77	$21,671,515,544	10 / 6
2026-08-28	$5.77	$21,671,515,544	10 / 6
2026-08-29	$5.77	$21,671,515,544	11 / 7
2026-08-30	$5.77	$21,671,515,544	11 / 7
2026-08-31	$5.77	$21,671,515,544	11 / 7
2026-09-01	$5.77	$21,671,515,544	11 / 7
2026-09-02	$5.77	$21,671,515,544	11 / 7
2026-09-03	$5.77	$21,671,515,544	11 / 7
2026-09-04	$5.77	$21,671,515,544	11 / 7
2026-09-05	$5.77	$21,671,515,544	11 / 7
2026-09-06	$5.77	$21,671,515,544	11 / 7
2026-09-07	$5.77	$21,671,515,544	11 / 7
2026-09-08	$5.77	$21,671,515,544	11 / 7
2026-09-09	$5.77	$21,671,515,544	11 / 7
2026-09-10	$5.77	$21,671,515,544	11 / 7
2026-09-11	$5.77	$21,671,515,544	11 / 7
2026-09-12	$5.77	$21,671,515,544	11 / 7
2026-09-13	$5.77	$21,671,515,544	11 / 7
2026-09-14	$5.77	$21,671,515,544	11 / 7
2026-09-15	$5.77	$21,671,515,544	11 / 7
2026-09-16	$5.77	$21,671,515,544	11 / 7
2026-09-17	$5.77	$21,653,313,955	11 / 7
2026-09-18	$5.77	$21,653,313,955	11 / 7
2026-09-19	$5.77	$21,653,313,955	11 / 7
2026-09-20	$5.77	$21,653,313,955	11 / 7
2026-09-21	$5.77	$21,653,313,955	11 / 7
2026-09-22	$5.77	$21,653,313,955	11 / 7
2026-09-23	$5.77	$21,653,313,955	11 / 7
2026-09-24	$5.77	$21,653,313,955	11 / 7
2026-09-25	$5.77	$21,664,647,289	11 / 7
2026-09-26	$5.77	$21,664,647,289	11 / 7
2026-09-27	$5.77	$21,664,647,289	11 / 7
2026-09-28	$5.77	$21,664,647,289	11 / 7
2026-09-29	$5.78	$21,417,362,054	11 / 7
2026-09-30	$5.78	$21,417,362,054	11 / 7
2026-10-01	$5.78	$21,417,362,054	11 / 7
2026-10-02	$5.77	$21,417,362,054	11 / 7
2026-10-03	$5.77	$21,417,362,054	11 / 7
2026-10-04	$5.77	$21,417,362,054	11 / 7
2026-10-05	$5.77	$21,417,362,054	11 / 7
2026-10-06	$5.77	$21,417,362,054	11 / 7
2026-10-07	$5.74	$21,147,044,692	11 / 7
2026-10-08	$5.73	$20,944,489,137	11 / 7
2026-10-09	$5.73	$20,944,489,137	11 / 7
2026-10-10	$5.73	$20,944,489,137	11 / 7
2026-10-11	$5.74	$20,944,489,137	11 / 7
2026-10-12	$5.74	$20,944,489,137	11 / 7
2026-10-13	$5.72	$20,974,159,325	11 / 7
2026-10-14	$5.72	$20,974,155,803	11 / 7
2026-10-15	$5.72	$20,974,155,803	11 / 7
2026-10-16	$5.72	$20,974,155,803	11 / 6
2026-10-17	$5.72	$20,974,155,803	11 / 6
2026-10-18	$5.73	$20,974,155,803	11 / 7
2026-10-19	$5.73	$20,974,155,803	11 / 7
2026-10-20	$5.73	$20,974,155,803	11 / 7
2026-10-21	$5.73	$20,974,155,803	11 / 7
2026-10-22	$5.73	$20,973,745,492	11 / 7
2026-10-23	$5.73	$20,973,745,492	11 / 6
2026-10-24	$5.73	$20,973,745,492	11 / 6

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	11	4
2026-06-01	11	4
2026-07-01	11	3
2026-08-01	11	3
2026-09-01	11	3
2026-10-01	11	3

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 11 Buy / Strong Buy · 3 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades6 maintains

Recent actions · Sep 25–Oct 24 · 6 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Mizuho SecuritiesOct 7 · prior Jul 9

$36.00 → $40.00+11.1%

UBSOct 6 · prior Apr 28

$29.00 → $36.00+24.1%

$0$22.00$44.00

2 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Return $1.4 billion to shareholders in 2026-Q1Direct metric needs a verified mapping
EPS reaches at least $4.42 in 2026Diluted EPS: $-0.04 per share
Complete merger with EquitableQualitative condition
Revenue growth near 10% per yearDirect metric needs a verified mapping

Next proof point

Nov 2, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.0%Typical daily move · historical

Downside history

-30.3%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Corebridge Financial outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a financial-sector business with a thesis tied to capital returns and a planned merger with Equitable, rather than a clearly established growth story. Its current state is watch, with weak recent performance and volatile management execution tempering progress on strategic priorities.

What's priced into Corebridge Financial

The valuation evidence points to CRBG being cheap versus peers, while the expectations gap is negative, meaning expectations appear to sit below the model’s baseline. The overall priced-in assessment is justified, with low fragility; the evidence does not show that valuation alone resolves the weak-results concern.

What the fundamentals likely do

Near term, recent earnings beats offer some support, but performance remains weak relative to the industry cohort and a prior deep miss is a relevant risk. Management has returned capital consistently and the Equitable merger has shareholder approval, with regulatory filings on track and a year-end 2026 close expected; integration and execution remain important. Digitization is a stated priority, but disclosed evidence of measurable progress is limited.

What Corebridge Financial hinges on

The merger’s completion and integration, along with continued delivery on capital returns, are central to the multi-year view. A guidance cut would be a meaningful negative, while rate cuts could add pressure given the sector backdrop. Continued strong results and higher guidance from financial-sector bellwethers such as BLK, BX, and KKR would be a favorable sector signal.